Publication | Closed Access

Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial

OncologyElderly PatientsMetronomic TherapyClinical TrialsGynecologyPharmacotherapySubgroup AnalysisCancer TreatmentMedicineGynecology OncologySingle-agent Bevacizumab-containing TherapyOvarian Cancer